Impact of health care professional interventions on completion of therapy in patients receiving high-dose interferon-alfa 2b adjuvant therapy for high-risk melanoma.
Teresa M. Petrella
Consultant or Advisory Role - Merck
Honoraria - Merck
Research Funding - Merck
Richard Tozer
Research Funding - Merck Canada
Gregory John Knight
Consultant or Advisory Role - Merck
Honoraria - Merck
Research Funding - Merck
Jose Chang
Honoraria - Merck
Research Funding - Merck
Bryn Lloyd Pressnail
Research Funding - Merck
Sudhashree Rajagopal
Consultant or Advisory Role - Merck
Honoraria - Merck
Research Funding - Merck
Nancy Gregorio
Research Funding - Merck
Other Remuneration - Merck
Caroline M. Hamm
Research Funding - Merck
Tina Cheng
Research Funding - Merck
Michael Smylie
Consultant or Advisory Role - Merck
Honoraria - Merck
Research Funding - Merck
Andre Galarneau
Employment or Leadership Position - Merck Canada
Jean-François Pouliot
Employment or Leadership Position - Merck Canada
Stock Ownership - Merck